Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Interest & Investment Income: 2014-2025

Historic Interest & Investment Income for KalVista Pharmaceuticals (KALV) over the last 7 years, with Apr 2025 value amounting to $1.4 million.

  • KalVista Pharmaceuticals' Interest & Investment Income fell 10.31% to $1.4 million in Q2 2025 from the same period last year, while for Apr 2025 it was $5.2 million, marking a year-over-year increase of 78.92%. This contributed to the annual value of $6.4 million for FY2025, which is 65.17% up from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Interest & Investment Income of $1.4 million as of Q2 2025, which was down 19.80% from $1.7 million recorded in Q3 2024.
  • Over the past 5 years, KalVista Pharmaceuticals' Interest & Investment Income peaked at $1.7 million during Q3 2024, and registered a low of $684,000 during Q1 2024.
  • For the 2-year period, KalVista Pharmaceuticals' Interest & Investment Income averaged around $1.3 million, with its median value being $1.4 million (2024).
  • Data for KalVista Pharmaceuticals' Interest & Investment Income shows a maximum YoY fell of 10.31% (in 2025) over the last 5 years.
  • KalVista Pharmaceuticals' Interest & Investment Income (Quarterly) stood at $1.7 million in 2024, then fell by 10.31% to $1.4 million in 2025.
  • Its Interest & Investment Income was $1.4 million in Q2 2025, compared to $1.7 million in Q3 2024 and $1.5 million in Q2 2024.